AI brief of an SEC Form 8-K · Quaker Chemical (KWR)

Quaker Chemical names Mark Douglas chairman as Michael Barry retires from board

Neutral Impact 3 of 5 leadership Written later

Michael F. Barry, who had served as Quaker Chemical's chairman since 2009 and as a director since 2008, retired from the board effective at the close of the May 13, 2026 meeting, and Mark A. Douglas was appointed chairman that day. The board also cut its size from eleven to ten directors and eliminated the lead director role, while shareholders at the 2026 annual meeting elected three directors and approved the company's executive pay and its auditor, PricewaterhouseCoopers.

Key points

  • Michael F. Barry retired from the board, effective at the conclusion of the May 13, 2026 board meeting; the filing says the decision was voluntary and not due to any disagreement with the company.
  • Mark A. Douglas, a director since 2013, was appointed chairman on May 13, 2026, succeeding Barry.
  • The board reduced its size from eleven to ten directors and eliminated the Lead Director role, which Jeffry D. Frisby had held since 2023; Frisby remains on the board.
  • Shareholders elected Nandita Bakhshi, Joseph A. Berquist and Charlotte C. Henry to three-year terms ending at the 2029 annual meeting and ratified PricewaterhouseCoopers LLP for fiscal 2026.

The filing

CompanyQuaker Chemical (KWR)
Form8-K, current report
Filed with the SECMay 15, 2026, 7:55 AM ET
Accession number0001628280-26-035318

Items reported: 5.02 Director / Officer Change5.07 Shareholder Vote Results7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 15, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.